Selskabets formål er direkte - eller indirekte ved besiddelse af aktier eller andre former for kapitalandele i danske virksomheder - at udøve virksomhed inden for Health Care eller inden for andre serviceområder. Selskabet kan udøve anden virksomhed, som efter bestyrelsens skøn står i forbindelse med ovennævnte formål.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 316.4 mio. | -23.4 mio. | 1.6 mia. | 474.5 mio. | 282 | |
CVR: 16165948
Secondary names: FALCK INTERNATIONAL A/S, FALCKEN SCANDINAVIA A/S, MEDICINSK TESTCENTER A/S
Previous names: FALCK SCANDINAVIA A/S, FALCK INTERNATIONAL A/S, FALCK HEALTH CARE A/S
Compared to 494 companies in Ikke-finansielle hovedsæders aktiviteter
Comparison is based on industry median values
Companies in the same industry and area
CVR 26438624
CVR 28681011
CVR 15694688
CVR 38635875
CVR 45767779
Camilla Zahle Borby Malthesen left the board
Marie Baastrup joined as ADM. DIR.
Anette Elisabeth Falisse Damgaard left as ADM. DIR.
Jacob Hedegaard Rasmussen left as director
FALCK HEALTHCARE A/S is currently facing significant financial challenges, as evidenced by its consistent losses over the past few years. In 2024, the company reported a revenue of 316.4 million DKK but incurred a loss of 23.4 million DKK, following a trend of declining profitability since 2022. Equity has decreased from 497.9 million DKK in 2023 to 474.5 million DKK in 2024, indicating a weakening financial position. Despite a relatively stable revenue stream, the persistent negative profit margins raise concerns about the company's operational efficiency and long-term viability within the non-financial headquarters industry.
AI-generated summary
companydata.dk